Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081481 | 12708148 | 1 | I | 20121128 | 20121215 | 20160901 | 20160901 | EXP | US-PFIZER INC-2012318763 | PFIZER | 71.00 | YR | M | Y | 84.00000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127081481 | 12708148 | 1 | PS | CELECOXIB. | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
| 127081481 | 12708148 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | 20998 | CAPSULE, HARD | |||||||||||
| 127081481 | 12708148 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, 1X/DAY | Y | 18667 | 20 | MG | QD | ||||||
| 127081481 | 12708148 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK, 1X/DAY | 0 | QD | |||||||||
| 127081481 | 12708148 | 5 | C | GLUCOSAMINE CHONDROITIN PM | 2 | UNK | 0 | ||||||||||||
| 127081481 | 12708148 | 6 | C | TAMSULOSIN | TAMSULOSIN | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 7 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 8 | C | SOLIFENACIN SUCCINATE. | SOLIFENACIN SUCCINATE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 9 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 10 | C | CALCIUM CARBONATE W/VITAMIN D | 2 | UNK | 0 | ||||||||||||
| 127081481 | 12708148 | 11 | C | CALCIUM CARBONATE W/VITAMIN D | 2 | 0 | |||||||||||||
| 127081481 | 12708148 | 12 | C | MAGNESIUM | MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 13 | C | GLIPIZIDE. | GLIPIZIDE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 14 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 15 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 16 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 17 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 18 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 19 | C | OMEGA 3 FATTY ACIDS | OMEGA-3 FATTY ACIDS | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 20 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 21 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 127081481 | 12708148 | 22 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127081481 | 12708148 | 1 | Osteoarthritis |
| 127081481 | 12708148 | 2 | Rheumatoid arthritis |
| 127081481 | 12708148 | 3 | Oedema |
| 127081481 | 12708148 | 4 | Prophylaxis |
| 127081481 | 12708148 | 5 | Osteoarthritis |
| 127081481 | 12708148 | 6 | Benign prostatic hyperplasia |
| 127081481 | 12708148 | 7 | Transient ischaemic attack |
| 127081481 | 12708148 | 8 | Hypertonic bladder |
| 127081481 | 12708148 | 9 | Constipation |
| 127081481 | 12708148 | 10 | Supplementation therapy |
| 127081481 | 12708148 | 11 | Muscle spasms |
| 127081481 | 12708148 | 12 | Muscle spasms |
| 127081481 | 12708148 | 13 | Type 2 diabetes mellitus |
| 127081481 | 12708148 | 14 | Type 2 diabetes mellitus |
| 127081481 | 12708148 | 15 | Hypertriglyceridaemia |
| 127081481 | 12708148 | 16 | Gastrooesophageal reflux disease |
| 127081481 | 12708148 | 17 | Hypertension |
| 127081481 | 12708148 | 18 | Hypertension |
| 127081481 | 12708148 | 19 | Hypertriglyceridaemia |
| 127081481 | 12708148 | 20 | Anaemia |
| 127081481 | 12708148 | 21 | Transient ischaemic attack |
| 127081481 | 12708148 | 22 | Osteoarthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127081481 | 12708148 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127081481 | 12708148 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127081481 | 12708148 | 1 | 20120907 | 20121107 | 0 | |
| 127081481 | 12708148 | 3 | 2000 | 20121128 | 0 | |
| 127081481 | 12708148 | 4 | 20120907 | 0 | ||
| 127081481 | 12708148 | 5 | 1979 | 0 | ||
| 127081481 | 12708148 | 6 | 2005 | 0 | ||
| 127081481 | 12708148 | 7 | 2000 | 0 | ||
| 127081481 | 12708148 | 8 | 2007 | 0 | ||
| 127081481 | 12708148 | 9 | 2003 | 0 | ||
| 127081481 | 12708148 | 10 | 1996 | 0 | ||
| 127081481 | 12708148 | 12 | 1998 | 0 | ||
| 127081481 | 12708148 | 13 | 2004 | 0 | ||
| 127081481 | 12708148 | 14 | 2006 | 0 | ||
| 127081481 | 12708148 | 15 | 2002 | 0 | ||
| 127081481 | 12708148 | 16 | 1982 | 0 | ||
| 127081481 | 12708148 | 17 | 2004 | 0 | ||
| 127081481 | 12708148 | 18 | 2004 | 0 | ||
| 127081481 | 12708148 | 19 | 1999 | 0 | ||
| 127081481 | 12708148 | 20 | 2002 | 0 | ||
| 127081481 | 12708148 | 21 | 2000 | 0 | ||
| 127081481 | 12708148 | 22 | 20120913 | 0 |